Eltrombopag treatment during induction chemotherapy for acute myeloid leukaemia: a randomised, double-blind, phase 2 study
Noelle Frey, Jun Ho Jang, Jeff Szer, Arpad Illes, Hee-Je Kim, Ron Ram, Beng H Chong, Jacob M Rowe, Elena Borisenkova, Jane Liesveld, Eric S Winer, Azzeddine Cherfi, Vassilios Aslanis, Farhat Ghaznawi, Stephen Strickland
The Lancet Haematology | ELSEVIER SCI LTD | Published : 2019
This study was funded by Novartis Pharma AG. We thank all the patients and co-investigators for their participation and contribution to this study. We thank Rebecca Helson of Mudskipper Business Ltd for medical editorial assistance. Financial support for medical editorial assistance was provided by Novartis Pharmaceuticals Corporation.